Total Payments
$1,217
2024 Payments
$210.34
Companies
13
Transactions
39
Medicare Patients
77
Medicare Billing
$9,574
Payment Breakdown by Category
Food & Beverage$939.39 (77.2%)
Education$277.95 (22.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $939.39 | 36 | 77.2% |
| Education | $277.95 | 3 | 22.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $385.93 | 17 | $0 (2024) |
| Seagen Inc. | $218.64 | 3 | $0 (2023) |
| Amgen Inc. | $124.36 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $123.58 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $89.00 | 1 | $0 (2023) |
| BeiGene USA, Inc. | $77.39 | 3 | $0 (2024) |
| PFIZER INC. | $42.99 | 2 | $0 (2023) |
| GENZYME CORPORATION | $36.92 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $27.90 | 1 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $27.54 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.34 | 11 | Merck Sharp & Dohme LLC ($123.58) |
| 2023 | $986.85 | 27 | Novartis Pharmaceuticals Corporation ($324.43) |
| 2022 | $20.15 | 1 | PFIZER INC. ($20.15) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Oncology | ||||||
| 05/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Oncology | ||||||
| 04/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 04/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Oncology | ||||||
| 11/15/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Oncology | ||||||
| 11/08/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Oncology | ||||||
| 10/31/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Oncology | ||||||
| 10/18/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Oncology | ||||||
| 09/06/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Oncology | ||||||
| 07/19/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Oncology | ||||||
| 06/14/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Oncology | ||||||
| 06/01/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Oncology | ||||||
| 05/27/2023 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Oncology | ||||||
| 05/24/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Oncology | ||||||
| 05/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Oncology | ||||||
| 05/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Education | In-kind items and services | $89.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 77 | 86 | $26,552 | $9,574 |
Total Patients
77
Total Services
86
Medicare Billing
$9,574
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 41 | 48 | $14,880 | $5,157 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 26 | $6,500 | $2,793 | 43.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $5,172 | $1,625 | 31.4% |
About Alexander Wu
Alexander Wu is a Internal Medicine healthcare provider based in Brewer, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2016. The National Provider Identifier (NPI) number assigned to this provider is 1285087817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alexander Wu has received a total of $1,217 in payments from pharmaceutical and medical device companies, with $210.34 received in 2024. These payments were reported across 39 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($939.39).
As a Medicare-enrolled provider, Wu has provided services to 77 Medicare beneficiaries, totaling 86 services with total Medicare billing of $9,574. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Brewer, ME
- Active Since 07/19/2016
- Last Updated 08/18/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285087817
Products in Payments
- SCEMBLIX (Drug) $365.56
- Nplate (Biological) $124.36
- KEYTRUDA (Biological) $123.58
- BRUKINSA (Drug) $77.39
- ENJAYMO (Biological) $36.92
- TUKYSA (Drug) $29.69
- LIBTAYO (Biological) $27.90
- ORGOVYX (Drug) $27.54
- Poteligeo (Drug) $24.97
- PREVNAR 20 (Biological) $22.84
- PROMACTA (Drug) $20.37
- BOSULIF (Drug) $20.15
- Nubeqa (Drug) $19.79
- XALKORI (Drug) $18.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.